The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»

Biotech stocks continued to langu.....»»

Biotech stocks continued to languish for a third straight week. Negative broader market sentiment and company-specific weakness weighed down on the sector. read more.....»»

Biotech stocks put up a muted performance in the week ended Sept. 20 amid conference presentations and FDA approvals. Johnson & Johnson (NYSE: JNJ)'.....»»

Biotech stocks had a relatively muted performance last week. Johnson & Johnson (NYSE: JNJ) kick started the second-quarter reporting season for big read more.....»»

Biotech stocks had a relatively muted performance last week. Johnson & Johnson (NYSE: JNJ) kick started the second-quarter reporting season for big pharma companies, beating forecasts a.....»»

Last week was a quiet one for the biotech space with the exception of a few clinical trial readouts. Pharma and biotech stocks took comfort in a ruling by a federal judge that went against President Donald Trump's initiative that.....»»

Last week was a quiet one for the biotech space with the exception of a few clinical trial readouts. read more.....»»

Biotech stocks.....»»

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Biotech stocks came under pressure in the week ending Feb. 22 after advancing in the previous week. The recent week was fairly quiet for the space, with a few earnings reports from small-cap stocks and a handful of conference presentations. read more.....»»

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. read more.....»»

Investors brace for a slew of earnings from Coca-Cola, Johnson & Johnson, United Airlines, Netflix, Chipotle, Intel, Snap, American Express and others in the coming week......»»

Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light on news, the week did witness earnings releases from smaller biopharma compani.....»»

Biotech stocks continued to move southwar.....»»

The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week. read more.....»»

The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along wi.....»»

The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. read more.....»»

Biotech stocks staged a nice recovery along with the broader markets in the week ended April 17. read more.....»»